Skip to content

Preclinical research with cancer genome profiling, FoundationOne CDx

Practical research with comprehensive cancer genome profiling under the purpose to develop precision medicine system for patients with cancer - Preclinical research with comprehensive CGP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050577
Enrollment
205
Registered
2023-03-14
Start date
2018-07-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumors

Interventions

None listed

Sponsors

Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University
Lead Sponsor
Chugai Pharmaceutical Co.,Ltd. Foundation Medicine Inc.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with malignant solid tumor pathologically from January 1, 2015 (2) Patients with high-grade tumors requiring perioperative chemotherapy or with unresectable or recurrent lesions (3) Patients who fully understand this research plan and can give their consent (4) Patients aged 20 years or older at the time of informed consent

Exclusion criteria

Exclusion criteria: Patients judged by researchers to be uneligible as research subjects

Design outcomes

Primary

MeasureTime frame
Frequency of detection of actionable genetic alternations

Countries

Japan

Contacts

Public ContactMakoto Kubo

Graduate School of Medical Sciences, Kyushu University Department of Surgery and Oncology

Kubo.makoto.804@m.kyushu-u.ac.jp092-642-5440

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026